nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—ABCB1—Mitomycin—urinary bladder cancer	0.134	0.219	CbGbCtD
Flurazepam—SLC22A2—Cisplatin—urinary bladder cancer	0.106	0.172	CbGbCtD
Flurazepam—CYP2A6—Fluorouracil—urinary bladder cancer	0.0992	0.161	CbGbCtD
Flurazepam—CYP3A4—Thiotepa—urinary bladder cancer	0.0611	0.0994	CbGbCtD
Flurazepam—CYP2E1—Etoposide—urinary bladder cancer	0.0546	0.0889	CbGbCtD
Flurazepam—ABCB1—Gemcitabine—urinary bladder cancer	0.0387	0.063	CbGbCtD
Flurazepam—ABCB1—Cisplatin—urinary bladder cancer	0.0281	0.0458	CbGbCtD
Flurazepam—ABCB1—Etoposide—urinary bladder cancer	0.0276	0.045	CbGbCtD
Flurazepam—ABCB1—Doxorubicin—urinary bladder cancer	0.0188	0.0307	CbGbCtD
Flurazepam—ABCB1—Methotrexate—urinary bladder cancer	0.0183	0.0297	CbGbCtD
Flurazepam—CYP3A4—Etoposide—urinary bladder cancer	0.0166	0.0269	CbGbCtD
Flurazepam—CYP3A4—Doxorubicin—urinary bladder cancer	0.0113	0.0184	CbGbCtD
Flurazepam—Midazolam—CYP4B1—urinary bladder cancer	0.00433	0.357	CrCbGaD
Flurazepam—CYP2E1—urine—urinary bladder cancer	0.00337	0.0704	CbGeAlD
Flurazepam—GABRP—prostate gland—urinary bladder cancer	0.00294	0.0614	CbGeAlD
Flurazepam—CYP3A4—urine—urinary bladder cancer	0.00271	0.0566	CbGeAlD
Flurazepam—Clonazepam—NAT2—urinary bladder cancer	0.00269	0.221	CrCbGaD
Flurazepam—CYP2A6—prostate gland—urinary bladder cancer	0.00256	0.0535	CbGeAlD
Flurazepam—Flunitrazepam—UGT2B7—urinary bladder cancer	0.00232	0.191	CrCbGaD
Flurazepam—GABRE—prostate gland—urinary bladder cancer	0.00224	0.0468	CbGeAlD
Flurazepam—CYP2A6—seminal vesicle—urinary bladder cancer	0.00217	0.0452	CbGeAlD
Flurazepam—SLC22A2—renal system—urinary bladder cancer	0.00206	0.043	CbGeAlD
Flurazepam—GABRP—urethra—urinary bladder cancer	0.00197	0.0411	CbGeAlD
Flurazepam—GABRB3—prostate gland—urinary bladder cancer	0.0019	0.0397	CbGeAlD
Flurazepam—GABRE—seminal vesicle—urinary bladder cancer	0.0019	0.0396	CbGeAlD
Flurazepam—Chloroquine—TNF—urinary bladder cancer	0.00175	0.144	CrCbGaD
Flurazepam—GABRB1—vagina—urinary bladder cancer	0.00162	0.0338	CbGeAlD
Flurazepam—GABRP—female reproductive system—urinary bladder cancer	0.0016	0.0335	CbGeAlD
Flurazepam—GABRE—urethra—urinary bladder cancer	0.0015	0.0314	CbGeAlD
Flurazepam—GABRP—vagina—urinary bladder cancer	0.00145	0.0303	CbGeAlD
Flurazepam—GABRR2—lymph node—urinary bladder cancer	0.00134	0.028	CbGeAlD
Flurazepam—CYP2A6—vagina—urinary bladder cancer	0.00126	0.0264	CbGeAlD
Flurazepam—GABRE—female reproductive system—urinary bladder cancer	0.00122	0.0256	CbGeAlD
Flurazepam—CYP2E1—prostate gland—urinary bladder cancer	0.00121	0.0253	CbGeAlD
Flurazepam—Tension—Thiotepa—urinary bladder cancer	0.00115	0.00413	CcSEcCtD
Flurazepam—Dysarthria—Epirubicin—urinary bladder cancer	0.00114	0.0041	CcSEcCtD
Flurazepam—Nervousness—Thiotepa—urinary bladder cancer	0.00114	0.00409	CcSEcCtD
Flurazepam—Nausea—Mitomycin—urinary bladder cancer	0.00113	0.00405	CcSEcCtD
Flurazepam—GABRA2—vagina—urinary bladder cancer	0.00112	0.0233	CbGeAlD
Flurazepam—GABRE—vagina—urinary bladder cancer	0.00111	0.0231	CbGeAlD
Flurazepam—Gait disturbance—Epirubicin—urinary bladder cancer	0.0011	0.00397	CcSEcCtD
Flurazepam—Vision blurred—Thiotepa—urinary bladder cancer	0.0011	0.00396	CcSEcCtD
Flurazepam—Thinking abnormal—Doxorubicin—urinary bladder cancer	0.00109	0.00392	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Epirubicin—urinary bladder cancer	0.00108	0.00387	CcSEcCtD
Flurazepam—Agitation—Thiotepa—urinary bladder cancer	0.00107	0.00387	CcSEcCtD
Flurazepam—Dysarthria—Doxorubicin—urinary bladder cancer	0.00105	0.00379	CcSEcCtD
Flurazepam—Coma—Methotrexate—urinary bladder cancer	0.00105	0.00378	CcSEcCtD
Flurazepam—Leukopenia—Thiotepa—urinary bladder cancer	0.00105	0.00377	CcSEcCtD
Flurazepam—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00105	0.00376	CcSEcCtD
Flurazepam—Clomipramine—GSTP1—urinary bladder cancer	0.00104	0.086	CrCbGaD
Flurazepam—GABRB3—female reproductive system—urinary bladder cancer	0.00104	0.0217	CbGeAlD
Flurazepam—CYP2E1—seminal vesicle—urinary bladder cancer	0.00102	0.0214	CbGeAlD
Flurazepam—Gait disturbance—Doxorubicin—urinary bladder cancer	0.00102	0.00367	CcSEcCtD
Flurazepam—Agranulocytosis—Etoposide—urinary bladder cancer	0.001	0.00361	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Doxorubicin—urinary bladder cancer	0.000997	0.00359	CcSEcCtD
Flurazepam—Arthralgia—Thiotepa—urinary bladder cancer	0.000996	0.00358	CcSEcCtD
Flurazepam—Anxiety—Thiotepa—urinary bladder cancer	0.000992	0.00357	CcSEcCtD
Flurazepam—Coma—Epirubicin—urinary bladder cancer	0.000984	0.00354	CcSEcCtD
Flurazepam—Flushing—Cisplatin—urinary bladder cancer	0.000978	0.00352	CcSEcCtD
Flurazepam—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.000968	0.00348	CcSEcCtD
Flurazepam—Confusional state—Thiotepa—urinary bladder cancer	0.000963	0.00346	CcSEcCtD
Flurazepam—Mental disability—Epirubicin—urinary bladder cancer	0.000935	0.00336	CcSEcCtD
Flurazepam—Vision blurred—Fluorouracil—urinary bladder cancer	0.000912	0.00328	CcSEcCtD
Flurazepam—Coma—Doxorubicin—urinary bladder cancer	0.000911	0.00328	CcSEcCtD
Flurazepam—Anorexia—Thiotepa—urinary bladder cancer	0.00091	0.00327	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Epirubicin—urinary bladder cancer	0.000899	0.00323	CcSEcCtD
Flurazepam—Flushing—Etoposide—urinary bladder cancer	0.000896	0.00322	CcSEcCtD
Flurazepam—Leukopenia—Gemcitabine—urinary bladder cancer	0.000881	0.00317	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00087	0.00313	CcSEcCtD
Flurazepam—Leukopenia—Fluorouracil—urinary bladder cancer	0.000866	0.00311	CcSEcCtD
Flurazepam—Mental disability—Doxorubicin—urinary bladder cancer	0.000865	0.00311	CcSEcCtD
Flurazepam—Vision blurred—Cisplatin—urinary bladder cancer	0.000864	0.00311	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000863	0.00311	CcSEcCtD
Flurazepam—Lethargy—Methotrexate—urinary bladder cancer	0.000853	0.00307	CcSEcCtD
Flurazepam—Somnolence—Thiotepa—urinary bladder cancer	0.000849	0.00305	CcSEcCtD
Flurazepam—Dyspepsia—Thiotepa—urinary bladder cancer	0.00084	0.00302	CcSEcCtD
Flurazepam—Chest pain—Gemcitabine—urinary bladder cancer	0.000838	0.00301	CcSEcCtD
Flurazepam—Arthralgia—Gemcitabine—urinary bladder cancer	0.000838	0.00301	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.000832	0.00299	CcSEcCtD
Flurazepam—Decreased appetite—Thiotepa—urinary bladder cancer	0.00083	0.00298	CcSEcCtD
Flurazepam—CYP2E1—renal system—urinary bladder cancer	0.000825	0.0172	CbGeAlD
Flurazepam—Chest pain—Fluorouracil—urinary bladder cancer	0.000824	0.00296	CcSEcCtD
Flurazepam—Dysgeusia—Etoposide—urinary bladder cancer	0.000823	0.00296	CcSEcCtD
Flurazepam—Leukopenia—Cisplatin—urinary bladder cancer	0.000821	0.00295	CcSEcCtD
Flurazepam—Constipation—Thiotepa—urinary bladder cancer	0.000816	0.00294	CcSEcCtD
Flurazepam—CYP2E1—urethra—urinary bladder cancer	0.00081	0.0169	CbGeAlD
Flurazepam—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000808	0.00291	CcSEcCtD
Flurazepam—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000803	0.00289	CcSEcCtD
Flurazepam—Lethargy—Epirubicin—urinary bladder cancer	0.000798	0.00287	CcSEcCtD
Flurazepam—Irritability—Methotrexate—urinary bladder cancer	0.000798	0.00287	CcSEcCtD
Flurazepam—Confusional state—Fluorouracil—urinary bladder cancer	0.000796	0.00286	CcSEcCtD
Flurazepam—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00079	0.00284	CcSEcCtD
Flurazepam—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000787	0.00283	CcSEcCtD
Flurazepam—Ataxia—Methotrexate—urinary bladder cancer	0.000786	0.00283	CcSEcCtD
Flurazepam—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000781	0.00281	CcSEcCtD
Flurazepam—Anxiety—Cisplatin—urinary bladder cancer	0.000778	0.0028	CcSEcCtD
Flurazepam—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000776	0.00279	CcSEcCtD
Flurazepam—Anorexia—Gemcitabine—urinary bladder cancer	0.000765	0.00275	CcSEcCtD
Flurazepam—Anorexia—Fluorouracil—urinary bladder cancer	0.000753	0.00271	CcSEcCtD
Flurazepam—Leukopenia—Etoposide—urinary bladder cancer	0.000752	0.0027	CcSEcCtD
Flurazepam—Hypotension—Gemcitabine—urinary bladder cancer	0.00075	0.0027	CcSEcCtD
Flurazepam—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000749	0.00269	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000748	0.00269	CcSEcCtD
Flurazepam—Loss of consciousness—Etoposide—urinary bladder cancer	0.000738	0.00266	CcSEcCtD
Flurazepam—Lethargy—Doxorubicin—urinary bladder cancer	0.000738	0.00266	CcSEcCtD
Flurazepam—Hypotension—Fluorouracil—urinary bladder cancer	0.000738	0.00265	CcSEcCtD
Flurazepam—Ataxia—Epirubicin—urinary bladder cancer	0.000735	0.00264	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000732	0.00263	CcSEcCtD
Flurazepam—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000724	0.0026	CcSEcCtD
Flurazepam—GABRA2—lymph node—urinary bladder cancer	0.000723	0.0151	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000719	0.00259	CcSEcCtD
Flurazepam—GABRE—lymph node—urinary bladder cancer	0.000717	0.015	CbGeAlD
Flurazepam—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000716	0.00257	CcSEcCtD
Flurazepam—Chest pain—Etoposide—urinary bladder cancer	0.000715	0.00257	CcSEcCtD
Flurazepam—Somnolence—Gemcitabine—urinary bladder cancer	0.000714	0.00257	CcSEcCtD
Flurazepam—Anorexia—Cisplatin—urinary bladder cancer	0.000713	0.00257	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000704	0.00253	CcSEcCtD
Flurazepam—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000704	0.00253	CcSEcCtD
Flurazepam—Somnolence—Fluorouracil—urinary bladder cancer	0.000702	0.00252	CcSEcCtD
Flurazepam—Hypotension—Cisplatin—urinary bladder cancer	0.000699	0.00252	CcSEcCtD
Flurazepam—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000698	0.00251	CcSEcCtD
Flurazepam—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000695	0.0025	CcSEcCtD
Flurazepam—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000692	0.00249	CcSEcCtD
Flurazepam—Confusional state—Etoposide—urinary bladder cancer	0.000691	0.00249	CcSEcCtD
Flurazepam—ABCB1—prostate gland—urinary bladder cancer	0.000689	0.0144	CbGeAlD
Flurazepam—Constipation—Gemcitabine—urinary bladder cancer	0.000687	0.00247	CcSEcCtD
Flurazepam—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000686	0.00247	CcSEcCtD
Flurazepam—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000686	0.00247	CcSEcCtD
Flurazepam—Asthenia—Thiotepa—urinary bladder cancer	0.000685	0.00246	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000682	0.00245	CcSEcCtD
Flurazepam—Ataxia—Doxorubicin—urinary bladder cancer	0.00068	0.00245	CcSEcCtD
Flurazepam—Pruritus—Thiotepa—urinary bladder cancer	0.000675	0.00243	CcSEcCtD
Flurazepam—Dyspnoea—Cisplatin—urinary bladder cancer	0.000667	0.0024	CcSEcCtD
Flurazepam—CYP3A4—renal system—urinary bladder cancer	0.000664	0.0139	CbGeAlD
Flurazepam—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000663	0.00238	CcSEcCtD
Flurazepam—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000662	0.00238	CcSEcCtD
Flurazepam—CYP2E1—female reproductive system—urinary bladder cancer	0.000661	0.0138	CbGeAlD
Flurazepam—Anorexia—Etoposide—urinary bladder cancer	0.000654	0.00235	CcSEcCtD
Flurazepam—Diarrhoea—Thiotepa—urinary bladder cancer	0.000653	0.00235	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000652	0.00234	CcSEcCtD
Flurazepam—Decreased appetite—Cisplatin—urinary bladder cancer	0.000651	0.00234	CcSEcCtD
Flurazepam—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000651	0.00234	CcSEcCtD
Flurazepam—Drowsiness—Methotrexate—urinary bladder cancer	0.000644	0.00232	CcSEcCtD
Flurazepam—Hypotension—Etoposide—urinary bladder cancer	0.000641	0.0023	CcSEcCtD
Flurazepam—Dizziness—Thiotepa—urinary bladder cancer	0.000631	0.00227	CcSEcCtD
Flurazepam—Sweating—Methotrexate—urinary bladder cancer	0.000617	0.00222	CcSEcCtD
Flurazepam—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000617	0.00222	CcSEcCtD
Flurazepam—Dyspnoea—Etoposide—urinary bladder cancer	0.000611	0.0022	CcSEcCtD
Flurazepam—Somnolence—Etoposide—urinary bladder cancer	0.00061	0.00219	CcSEcCtD
Flurazepam—Vomiting—Thiotepa—urinary bladder cancer	0.000607	0.00218	CcSEcCtD
Flurazepam—Drowsiness—Epirubicin—urinary bladder cancer	0.000603	0.00217	CcSEcCtD
Flurazepam—Rash—Thiotepa—urinary bladder cancer	0.000602	0.00216	CcSEcCtD
Flurazepam—Dermatitis—Thiotepa—urinary bladder cancer	0.000601	0.00216	CcSEcCtD
Flurazepam—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000601	0.00216	CcSEcCtD
Flurazepam—Headache—Thiotepa—urinary bladder cancer	0.000598	0.00215	CcSEcCtD
Flurazepam—Decreased appetite—Etoposide—urinary bladder cancer	0.000596	0.00214	CcSEcCtD
Flurazepam—Constipation—Etoposide—urinary bladder cancer	0.000586	0.00211	CcSEcCtD
Flurazepam—ABCB1—seminal vesicle—urinary bladder cancer	0.000583	0.0122	CbGeAlD
Flurazepam—Sweating—Epirubicin—urinary bladder cancer	0.000578	0.00208	CcSEcCtD
Flurazepam—Asthenia—Gemcitabine—urinary bladder cancer	0.000576	0.00207	CcSEcCtD
Flurazepam—Pruritus—Gemcitabine—urinary bladder cancer	0.000568	0.00204	CcSEcCtD
Flurazepam—Nausea—Thiotepa—urinary bladder cancer	0.000567	0.00204	CcSEcCtD
Flurazepam—Feeling abnormal—Etoposide—urinary bladder cancer	0.000565	0.00203	CcSEcCtD
Flurazepam—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000562	0.00202	CcSEcCtD
Flurazepam—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000561	0.00202	CcSEcCtD
Flurazepam—Pruritus—Fluorouracil—urinary bladder cancer	0.000559	0.00201	CcSEcCtD
Flurazepam—Drowsiness—Doxorubicin—urinary bladder cancer	0.000558	0.00201	CcSEcCtD
Flurazepam—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000549	0.00198	CcSEcCtD
Flurazepam—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00054	0.00194	CcSEcCtD
Flurazepam—Asthenia—Cisplatin—urinary bladder cancer	0.000537	0.00193	CcSEcCtD
Flurazepam—Sweating—Doxorubicin—urinary bladder cancer	0.000535	0.00192	CcSEcCtD
Flurazepam—CYP3A4—female reproductive system—urinary bladder cancer	0.000532	0.0111	CbGeAlD
Flurazepam—Dizziness—Fluorouracil—urinary bladder cancer	0.000522	0.00188	CcSEcCtD
Flurazepam—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00052	0.00187	CcSEcCtD
Flurazepam—Diarrhoea—Cisplatin—urinary bladder cancer	0.000512	0.00184	CcSEcCtD
Flurazepam—Vomiting—Gemcitabine—urinary bladder cancer	0.000511	0.00184	CcSEcCtD
Flurazepam—ABCB1—epithelium—urinary bladder cancer	0.000506	0.0106	CbGeAlD
Flurazepam—Rash—Gemcitabine—urinary bladder cancer	0.000506	0.00182	CcSEcCtD
Flurazepam—Dermatitis—Gemcitabine—urinary bladder cancer	0.000506	0.00182	CcSEcCtD
Flurazepam—Headache—Gemcitabine—urinary bladder cancer	0.000503	0.00181	CcSEcCtD
Flurazepam—Flushing—Epirubicin—urinary bladder cancer	0.000502	0.00181	CcSEcCtD
Flurazepam—Vomiting—Fluorouracil—urinary bladder cancer	0.000502	0.00181	CcSEcCtD
Flurazepam—Rash—Fluorouracil—urinary bladder cancer	0.000498	0.00179	CcSEcCtD
Flurazepam—Dermatitis—Fluorouracil—urinary bladder cancer	0.000497	0.00179	CcSEcCtD
Flurazepam—Headache—Fluorouracil—urinary bladder cancer	0.000495	0.00178	CcSEcCtD
Flurazepam—Dysgeusia—Methotrexate—urinary bladder cancer	0.000493	0.00177	CcSEcCtD
Flurazepam—Asthenia—Etoposide—urinary bladder cancer	0.000492	0.00177	CcSEcCtD
Flurazepam—Pruritus—Etoposide—urinary bladder cancer	0.000485	0.00174	CcSEcCtD
Flurazepam—Nausea—Gemcitabine—urinary bladder cancer	0.000477	0.00172	CcSEcCtD
Flurazepam—Vomiting—Cisplatin—urinary bladder cancer	0.000476	0.00171	CcSEcCtD
Flurazepam—Vision blurred—Methotrexate—urinary bladder cancer	0.000474	0.00171	CcSEcCtD
Flurazepam—Rash—Cisplatin—urinary bladder cancer	0.000472	0.0017	CcSEcCtD
Flurazepam—Dermatitis—Cisplatin—urinary bladder cancer	0.000472	0.0017	CcSEcCtD
Flurazepam—ABCB1—renal system—urinary bladder cancer	0.00047	0.00981	CbGeAlD
Flurazepam—Diarrhoea—Etoposide—urinary bladder cancer	0.000469	0.00169	CcSEcCtD
Flurazepam—Nausea—Fluorouracil—urinary bladder cancer	0.000469	0.00169	CcSEcCtD
Flurazepam—Flushing—Doxorubicin—urinary bladder cancer	0.000465	0.00167	CcSEcCtD
Flurazepam—Tension—Epirubicin—urinary bladder cancer	0.000462	0.00166	CcSEcCtD
Flurazepam—ABCB1—urethra—urinary bladder cancer	0.000461	0.00963	CbGeAlD
Flurazepam—Dysgeusia—Epirubicin—urinary bladder cancer	0.000461	0.00166	CcSEcCtD
Flurazepam—Nervousness—Epirubicin—urinary bladder cancer	0.000457	0.00164	CcSEcCtD
Flurazepam—Dizziness—Etoposide—urinary bladder cancer	0.000453	0.00163	CcSEcCtD
Flurazepam—Leukopenia—Methotrexate—urinary bladder cancer	0.000451	0.00162	CcSEcCtD
Flurazepam—Nausea—Cisplatin—urinary bladder cancer	0.000445	0.0016	CcSEcCtD
Flurazepam—Vision blurred—Epirubicin—urinary bladder cancer	0.000444	0.0016	CcSEcCtD
Flurazepam—Vomiting—Etoposide—urinary bladder cancer	0.000436	0.00157	CcSEcCtD
Flurazepam—Agitation—Epirubicin—urinary bladder cancer	0.000433	0.00156	CcSEcCtD
Flurazepam—Rash—Etoposide—urinary bladder cancer	0.000432	0.00155	CcSEcCtD
Flurazepam—Dermatitis—Etoposide—urinary bladder cancer	0.000432	0.00155	CcSEcCtD
Flurazepam—Headache—Etoposide—urinary bladder cancer	0.00043	0.00154	CcSEcCtD
Flurazepam—Arthralgia—Methotrexate—urinary bladder cancer	0.000428	0.00154	CcSEcCtD
Flurazepam—Chest pain—Methotrexate—urinary bladder cancer	0.000428	0.00154	CcSEcCtD
Flurazepam—Tension—Doxorubicin—urinary bladder cancer	0.000428	0.00154	CcSEcCtD
Flurazepam—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000427	0.00153	CcSEcCtD
Flurazepam—Nervousness—Doxorubicin—urinary bladder cancer	0.000423	0.00152	CcSEcCtD
Flurazepam—Syncope—Epirubicin—urinary bladder cancer	0.000422	0.00152	CcSEcCtD
Flurazepam—Leukopenia—Epirubicin—urinary bladder cancer	0.000422	0.00152	CcSEcCtD
Flurazepam—Palpitations—Epirubicin—urinary bladder cancer	0.000416	0.0015	CcSEcCtD
Flurazepam—Confusional state—Methotrexate—urinary bladder cancer	0.000414	0.00149	CcSEcCtD
Flurazepam—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000414	0.00149	CcSEcCtD
Flurazepam—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000411	0.00148	CcSEcCtD
Flurazepam—Vision blurred—Doxorubicin—urinary bladder cancer	0.000411	0.00148	CcSEcCtD
Flurazepam—Nausea—Etoposide—urinary bladder cancer	0.000407	0.00146	CcSEcCtD
Flurazepam—Arthralgia—Epirubicin—urinary bladder cancer	0.000401	0.00144	CcSEcCtD
Flurazepam—Chest pain—Epirubicin—urinary bladder cancer	0.000401	0.00144	CcSEcCtD
Flurazepam—Agitation—Doxorubicin—urinary bladder cancer	0.0004	0.00144	CcSEcCtD
Flurazepam—Anxiety—Epirubicin—urinary bladder cancer	0.0004	0.00144	CcSEcCtD
Flurazepam—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000397	0.00143	CcSEcCtD
Flurazepam—Dry mouth—Epirubicin—urinary bladder cancer	0.000392	0.00141	CcSEcCtD
Flurazepam—Anorexia—Methotrexate—urinary bladder cancer	0.000392	0.00141	CcSEcCtD
Flurazepam—Syncope—Doxorubicin—urinary bladder cancer	0.000391	0.00141	CcSEcCtD
Flurazepam—Leukopenia—Doxorubicin—urinary bladder cancer	0.00039	0.0014	CcSEcCtD
Flurazepam—Confusional state—Epirubicin—urinary bladder cancer	0.000388	0.00139	CcSEcCtD
Flurazepam—Palpitations—Doxorubicin—urinary bladder cancer	0.000385	0.00138	CcSEcCtD
Flurazepam—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000384	0.00138	CcSEcCtD
Flurazepam—Hypotension—Methotrexate—urinary bladder cancer	0.000384	0.00138	CcSEcCtD
Flurazepam—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000383	0.00138	CcSEcCtD
Flurazepam—Shock—Epirubicin—urinary bladder cancer	0.000378	0.00136	CcSEcCtD
Flurazepam—ABCB1—female reproductive system—urinary bladder cancer	0.000376	0.00785	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000374	0.00135	CcSEcCtD
Flurazepam—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000372	0.00134	CcSEcCtD
Flurazepam—Arthralgia—Doxorubicin—urinary bladder cancer	0.000371	0.00133	CcSEcCtD
Flurazepam—Chest pain—Doxorubicin—urinary bladder cancer	0.000371	0.00133	CcSEcCtD
Flurazepam—Anxiety—Doxorubicin—urinary bladder cancer	0.00037	0.00133	CcSEcCtD
Flurazepam—Anorexia—Epirubicin—urinary bladder cancer	0.000366	0.00132	CcSEcCtD
Flurazepam—Dyspnoea—Methotrexate—urinary bladder cancer	0.000366	0.00132	CcSEcCtD
Flurazepam—Somnolence—Methotrexate—urinary bladder cancer	0.000365	0.00131	CcSEcCtD
Flurazepam—Dry mouth—Doxorubicin—urinary bladder cancer	0.000363	0.0013	CcSEcCtD
Flurazepam—Dyspepsia—Methotrexate—urinary bladder cancer	0.000362	0.0013	CcSEcCtD
Flurazepam—Hypotension—Epirubicin—urinary bladder cancer	0.000359	0.00129	CcSEcCtD
Flurazepam—Confusional state—Doxorubicin—urinary bladder cancer	0.000359	0.00129	CcSEcCtD
Flurazepam—Decreased appetite—Methotrexate—urinary bladder cancer	0.000357	0.00128	CcSEcCtD
Flurazepam—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000356	0.00128	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00035	0.00126	CcSEcCtD
Flurazepam—Shock—Doxorubicin—urinary bladder cancer	0.00035	0.00126	CcSEcCtD
Flurazepam—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000344	0.00124	CcSEcCtD
Flurazepam—Dyspnoea—Epirubicin—urinary bladder cancer	0.000343	0.00123	CcSEcCtD
Flurazepam—Somnolence—Epirubicin—urinary bladder cancer	0.000342	0.00123	CcSEcCtD
Flurazepam—ABCB1—vagina—urinary bladder cancer	0.00034	0.0071	CbGeAlD
Flurazepam—Anorexia—Doxorubicin—urinary bladder cancer	0.000339	0.00122	CcSEcCtD
Flurazepam—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000338	0.00122	CcSEcCtD
Flurazepam—Dyspepsia—Epirubicin—urinary bladder cancer	0.000338	0.00122	CcSEcCtD
Flurazepam—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000336	0.00121	CcSEcCtD
Flurazepam—Decreased appetite—Epirubicin—urinary bladder cancer	0.000334	0.0012	CcSEcCtD
Flurazepam—Hypotension—Doxorubicin—urinary bladder cancer	0.000332	0.0012	CcSEcCtD
Flurazepam—Constipation—Epirubicin—urinary bladder cancer	0.000329	0.00118	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000324	0.00117	CcSEcCtD
Flurazepam—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000317	0.00114	CcSEcCtD
Flurazepam—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000317	0.00114	CcSEcCtD
Flurazepam—Somnolence—Doxorubicin—urinary bladder cancer	0.000316	0.00114	CcSEcCtD
Flurazepam—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000314	0.00113	CcSEcCtD
Flurazepam—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000313	0.00113	CcSEcCtD
Flurazepam—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000309	0.00111	CcSEcCtD
Flurazepam—Constipation—Doxorubicin—urinary bladder cancer	0.000304	0.00109	CcSEcCtD
Flurazepam—Asthenia—Methotrexate—urinary bladder cancer	0.000295	0.00106	CcSEcCtD
Flurazepam—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000293	0.00105	CcSEcCtD
Flurazepam—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000291	0.00105	CcSEcCtD
Flurazepam—Pruritus—Methotrexate—urinary bladder cancer	0.000291	0.00105	CcSEcCtD
Flurazepam—Diarrhoea—Methotrexate—urinary bladder cancer	0.000281	0.00101	CcSEcCtD
Flurazepam—Asthenia—Epirubicin—urinary bladder cancer	0.000276	0.000992	CcSEcCtD
Flurazepam—Pruritus—Epirubicin—urinary bladder cancer	0.000272	0.000978	CcSEcCtD
Flurazepam—Dizziness—Methotrexate—urinary bladder cancer	0.000272	0.000977	CcSEcCtD
Flurazepam—Diarrhoea—Epirubicin—urinary bladder cancer	0.000263	0.000946	CcSEcCtD
Flurazepam—Vomiting—Methotrexate—urinary bladder cancer	0.000261	0.000939	CcSEcCtD
Flurazepam—Rash—Methotrexate—urinary bladder cancer	0.000259	0.000931	CcSEcCtD
Flurazepam—Dermatitis—Methotrexate—urinary bladder cancer	0.000259	0.00093	CcSEcCtD
Flurazepam—Headache—Methotrexate—urinary bladder cancer	0.000257	0.000925	CcSEcCtD
Flurazepam—Asthenia—Doxorubicin—urinary bladder cancer	0.000255	0.000918	CcSEcCtD
Flurazepam—Dizziness—Epirubicin—urinary bladder cancer	0.000254	0.000914	CcSEcCtD
Flurazepam—Pruritus—Doxorubicin—urinary bladder cancer	0.000252	0.000905	CcSEcCtD
Flurazepam—Vomiting—Epirubicin—urinary bladder cancer	0.000244	0.000879	CcSEcCtD
Flurazepam—Nausea—Methotrexate—urinary bladder cancer	0.000244	0.000877	CcSEcCtD
Flurazepam—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000243	0.000875	CcSEcCtD
Flurazepam—Rash—Epirubicin—urinary bladder cancer	0.000242	0.000872	CcSEcCtD
Flurazepam—Dermatitis—Epirubicin—urinary bladder cancer	0.000242	0.000871	CcSEcCtD
Flurazepam—Headache—Epirubicin—urinary bladder cancer	0.000241	0.000866	CcSEcCtD
Flurazepam—Dizziness—Doxorubicin—urinary bladder cancer	0.000235	0.000846	CcSEcCtD
Flurazepam—Nausea—Epirubicin—urinary bladder cancer	0.000228	0.000821	CcSEcCtD
Flurazepam—Vomiting—Doxorubicin—urinary bladder cancer	0.000226	0.000813	CcSEcCtD
Flurazepam—Rash—Doxorubicin—urinary bladder cancer	0.000224	0.000806	CcSEcCtD
Flurazepam—Dermatitis—Doxorubicin—urinary bladder cancer	0.000224	0.000806	CcSEcCtD
Flurazepam—Headache—Doxorubicin—urinary bladder cancer	0.000223	0.000801	CcSEcCtD
Flurazepam—ABCB1—lymph node—urinary bladder cancer	0.00022	0.00459	CbGeAlD
Flurazepam—Nausea—Doxorubicin—urinary bladder cancer	0.000211	0.00076	CcSEcCtD
Flurazepam—GABRA6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7e-05	0.00148	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	6.99e-05	0.00147	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	6.98e-05	0.00147	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.91e-05	0.00146	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.87e-05	0.00145	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	6.82e-05	0.00144	CbGpPWpGaD
Flurazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.74e-05	0.00142	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.73e-05	0.00142	CbGpPWpGaD
Flurazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.43e-05	0.00135	CbGpPWpGaD
Flurazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.43e-05	0.00135	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	6.37e-05	0.00134	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.32e-05	0.00133	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	6.27e-05	0.00132	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.18e-05	0.0013	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.14e-05	0.0013	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.03e-05	0.00127	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.93e-05	0.00125	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.89e-05	0.00124	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	5.89e-05	0.00124	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	5.81e-05	0.00122	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.78e-05	0.00122	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	5.76e-05	0.00122	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTZ1—urinary bladder cancer	5.76e-05	0.00121	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	5.62e-05	0.00119	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	5.56e-05	0.00117	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTO2—urinary bladder cancer	5.46e-05	0.00115	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NAT1—urinary bladder cancer	5.46e-05	0.00115	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.29e-05	0.00112	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	5.29e-05	0.00111	CbGpPWpGaD
Flurazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	5.27e-05	0.00111	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.21e-05	0.0011	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.06e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.06e-05	0.00107	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NAT1—urinary bladder cancer	5.01e-05	0.00106	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	5.01e-05	0.00106	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—UGT2B7—urinary bladder cancer	4.99e-05	0.00105	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.93e-05	0.00104	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.87e-05	0.00103	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.83e-05	0.00102	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.83e-05	0.00102	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	4.81e-05	0.00101	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	4.77e-05	0.00101	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	4.76e-05	0.001	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.71e-05	0.000993	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.64e-05	0.000979	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.61e-05	0.000971	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	4.6e-05	0.000969	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	4.59e-05	0.000967	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.57e-05	0.000963	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP4B1—urinary bladder cancer	4.5e-05	0.000948	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.48e-05	0.000944	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	4.47e-05	0.000943	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.45e-05	0.000939	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	4.39e-05	0.000926	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.33e-05	0.000912	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.27e-05	0.0009	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.27e-05	0.0009	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.25e-05	0.000896	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC19A1—urinary bladder cancer	4.25e-05	0.000895	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	4.18e-05	0.000881	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.18e-05	0.00088	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.15e-05	0.000875	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PRSS3—urinary bladder cancer	4.14e-05	0.000873	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	4.13e-05	0.00087	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.07e-05	0.000859	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	4.06e-05	0.000855	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.98e-05	0.000839	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	3.96e-05	0.000835	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NAT1—urinary bladder cancer	3.96e-05	0.000835	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.92e-05	0.000826	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	3.9e-05	0.000822	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	3.89e-05	0.00082	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—HRAS—urinary bladder cancer	3.88e-05	0.000818	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	3.87e-05	0.000817	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	3.8e-05	0.000801	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.75e-05	0.000791	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.71e-05	0.000782	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—HRAS—urinary bladder cancer	3.7e-05	0.00078	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—HRAS—urinary bladder cancer	3.7e-05	0.00078	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.66e-05	0.000772	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	3.62e-05	0.000764	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.56e-05	0.000751	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.52e-05	0.000741	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.46e-05	0.00073	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.44e-05	0.000725	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.42e-05	0.000722	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.41e-05	0.000719	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.35e-05	0.000706	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.35e-05	0.000706	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TYMP—urinary bladder cancer	3.31e-05	0.000698	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.28e-05	0.000691	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	3.26e-05	0.000688	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.25e-05	0.000686	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.24e-05	0.000682	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.19e-05	0.000673	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.17e-05	0.000667	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.15e-05	0.000663	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.14e-05	0.000662	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.12e-05	0.000658	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.12e-05	0.000658	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	3.08e-05	0.00065	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.06e-05	0.000646	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—HRAS—urinary bladder cancer	3.05e-05	0.000643	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TYMP—urinary bladder cancer	3.04e-05	0.00064	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—HRAS—urinary bladder cancer	3e-05	0.000633	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	3e-05	0.000633	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NAT2—urinary bladder cancer	2.99e-05	0.000631	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	2.99e-05	0.00063	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTO2—urinary bladder cancer	2.98e-05	0.000629	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NAT1—urinary bladder cancer	2.98e-05	0.000629	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.96e-05	0.000624	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	2.95e-05	0.000622	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.91e-05	0.000613	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.88e-05	0.000606	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.87e-05	0.000605	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—HRAS—urinary bladder cancer	2.84e-05	0.000599	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.82e-05	0.000595	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—HRAS—urinary bladder cancer	2.81e-05	0.000591	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.77e-05	0.000585	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.76e-05	0.000581	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NAT2—urinary bladder cancer	2.75e-05	0.000579	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.73e-05	0.000575	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.71e-05	0.000571	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.68e-05	0.000564	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—RRM2—urinary bladder cancer	2.58e-05	0.000545	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—HRAS—urinary bladder cancer	2.57e-05	0.000541	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.54e-05	0.000535	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.5e-05	0.000528	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—HRAS—urinary bladder cancer	2.49e-05	0.000525	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.46e-05	0.000518	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.46e-05	0.000518	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—HRAS—urinary bladder cancer	2.45e-05	0.000516	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.45e-05	0.000516	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—HRAS—urinary bladder cancer	2.41e-05	0.000507	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TYMP—urinary bladder cancer	2.4e-05	0.000506	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	2.39e-05	0.000504	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ENO2—urinary bladder cancer	2.39e-05	0.000504	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—HRAS—urinary bladder cancer	2.39e-05	0.000504	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—RRM2—urinary bladder cancer	2.37e-05	0.0005	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.37e-05	0.000499	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—HRAS—urinary bladder cancer	2.35e-05	0.000495	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	2.32e-05	0.000489	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.32e-05	0.000489	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.26e-05	0.000477	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.21e-05	0.000466	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	2.2e-05	0.000463	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ENO2—urinary bladder cancer	2.2e-05	0.000463	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.17e-05	0.000458	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NAT2—urinary bladder cancer	2.17e-05	0.000458	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.14e-05	0.000451	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.13e-05	0.00045	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	2.13e-05	0.000449	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—HRAS—urinary bladder cancer	2.05e-05	0.000432	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.04e-05	0.000429	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.98e-05	0.000417	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.94e-05	0.000409	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NQO1—urinary bladder cancer	1.93e-05	0.000406	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	1.88e-05	0.000397	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—RRM2—urinary bladder cancer	1.87e-05	0.000395	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.84e-05	0.000388	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.84e-05	0.000388	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.81e-05	0.000381	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.77e-05	0.000374	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.000373	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ENO2—urinary bladder cancer	1.74e-05	0.000366	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	1.74e-05	0.000366	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.73e-05	0.000366	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	1.68e-05	0.000355	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.68e-05	0.000354	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.65e-05	0.000348	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.64e-05	0.000346	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.63e-05	0.000345	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	1.61e-05	0.000339	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.51e-05	0.000319	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TYMS—urinary bladder cancer	1.5e-05	0.000315	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	1.48e-05	0.000312	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	1.48e-05	0.000312	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000311	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.46e-05	0.000307	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.43e-05	0.000301	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPX1—urinary bladder cancer	1.42e-05	0.000298	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.41e-05	0.000297	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.4e-05	0.000295	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.39e-05	0.000294	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	1.39e-05	0.000293	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.000289	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000286	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000286	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.31e-05	0.000275	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.31e-05	0.000275	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	1.31e-05	0.000275	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000274	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000269	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.27e-05	0.000267	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000253	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.19e-05	0.00025	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.17e-05	0.000246	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.11e-05	0.000235	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.08e-05	0.000229	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.07e-05	0.000226	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.07e-05	0.000226	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PPARG—urinary bladder cancer	1.06e-05	0.000223	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.05e-05	0.000222	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.03e-05	0.000216	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	1.02e-05	0.000214	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.01e-05	0.000213	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.01e-05	0.000212	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PPARG—urinary bladder cancer	9.72e-06	0.000205	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	9.48e-06	0.0002	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	9.34e-06	0.000197	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.79e-06	0.000185	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.69e-06	0.000183	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	8.33e-06	0.000176	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TYMS—urinary bladder cancer	8.17e-06	0.000172	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NCOR1—urinary bladder cancer	8.07e-06	0.00017	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTM1—urinary bladder cancer	8.07e-06	0.00017	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.05e-06	0.00017	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.05e-06	0.00017	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.81e-06	0.000165	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.73e-06	0.000163	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PPARG—urinary bladder cancer	7.68e-06	0.000162	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	7.65e-06	0.000161	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.59e-06	0.00016	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	7.38e-06	0.000156	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTEN—urinary bladder cancer	7.27e-06	0.000153	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MTHFR—urinary bladder cancer	7.14e-06	0.00015	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—EP300—urinary bladder cancer	6.93e-06	0.000146	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTEN—urinary bladder cancer	6.67e-06	0.000141	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.49e-06	0.000137	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—EP300—urinary bladder cancer	6.36e-06	0.000134	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	6.04e-06	0.000127	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.79e-06	0.000122	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.56e-06	0.000117	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.41e-06	0.000114	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTEN—urinary bladder cancer	5.27e-06	0.000111	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.03e-06	0.000106	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—EP300—urinary bladder cancer	5.03e-06	0.000106	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.97e-06	0.000105	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.97e-06	0.000105	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.76e-06	0.0001	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.68e-06	9.86e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.55e-06	9.6e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.4e-06	9.27e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.97e-06	8.37e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—EP300—urinary bladder cancer	3.79e-06	7.98e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.56e-06	7.52e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.42e-06	7.22e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.8e-06	5.91e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.45e-06	5.16e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.33e-06	4.92e-05	CbGpPWpGaD
